Monographie - Dexrazoxane hydrochloride - Stabilis 4.0

Last update :
19/11/2024

Cytoprotective

Dexrazoxane hydrochloride

injection

Stability in solutions

Stability of mixtures

Factors which affect stability

Compatibility

Route of administration

References

pdf

Chemical structure

Tradename

Tradename

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cardioxane	Austria, Brazil, Chile, Denmark, Ecuador, France, Germany, Great Britain, Hungary, Ireland, Italy, Mexico, Peru, Poland, Spain, Venezuela
Cyrdanax	France, Germany
Dexrazoxane	Ecuador, United States of America
Dexrazoxano	Mexico, Peru
Razox	Peru
Razoxane	Colombia
Rhianta	Mexico
Savene	Belgium, Denmark, Finland, France, Germany, Great Britain, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Romania, Spain, Sweden
Zinecard	Canada, United States of America
Zucordex	Mexico

References

injection

References : Dexrazoxane hydrochloride

	Type	Publication
381	Journal	Beijnen JH, Van Gijn R. Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids. J Parenter Sci Technol 1993 ; 47: 166-171.
1423	Journal	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1754	Journal	Trissel LA, Gilbert DL, Wolkin AC. Compatibility of docetaxel with selected drugs during simulated Y-site administration. Int J Pharm Compound 1999 ; 3: 241-244.
1949	Journal	Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH. Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies. Clinical Cancer Research 2001 ; 7: 1569-1576.
1953	Journal	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
2201	Journal	Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B. Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers. EJHP Science 2007 ; 13, 3: 55-59.
2224	Journal	Romanazzi C, Sferra S, Campi A, Rabino B, Barbieri M, Castellani S, Sabbatini L, Scanavacca P. Dexrazoxane: Stabilià in soluzione. Bolletino SIFO 2007 ; 53: 178-180.
3581	Manufacturer	Dexrazoxane (Cardioxane®) - Résumé des caractéristiques du produit Clinigen Healthcare 2013
3611	Journal	Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T. Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions. J Oncol Pharm Practice 2014 ; 20, 1: 58-64.

Mentions Légales